These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


450 related items for PubMed ID: 17684524

  • 1. Direct and indirect cellular effects of aspartame on the brain.
    Humphries P, Pretorius E, Naudé H.
    Eur J Clin Nutr; 2008 Apr; 62(4):451-62. PubMed ID: 17684524
    [Abstract] [Full Text] [Related]

  • 2. The debate over neurotransmitter interaction in aspartame usage.
    Choudhary AK, Lee YY.
    J Clin Neurosci; 2018 Oct; 56():7-15. PubMed ID: 30318075
    [Abstract] [Full Text] [Related]

  • 3. Use of aspartame in pregnancy.
    Sturtevant FM.
    Int J Fertil; 1985 Oct; 30(1):85-7. PubMed ID: 2862125
    [Abstract] [Full Text] [Related]

  • 4. l-Cysteine and glutathione restore the modulation of rat frontal cortex Na+, K+ -ATPase activity induced by aspartame metabolites.
    Simintzi I, Schulpis KH, Angelogianni P, Liapi C, Tsakiris S.
    Food Chem Toxicol; 2008 Jun; 46(6):2074-9. PubMed ID: 18343556
    [Abstract] [Full Text] [Related]

  • 5. Effects of aspartame metabolites on astrocytes and neurons.
    Rycerz K, Jaworska-Adamu JE.
    Folia Neuropathol; 2013 Jun; 51(1):10-7. PubMed ID: 23553132
    [Abstract] [Full Text] [Related]

  • 6. The effect of aspartame metabolites on human erythrocyte membrane acetylcholinesterase activity.
    Tsakiris S, Giannoulia-Karantana A, Simintzi I, Schulpis KH.
    Pharmacol Res; 2006 Jan; 53(1):1-5. PubMed ID: 16129618
    [Abstract] [Full Text] [Related]

  • 7. The effect of L-cysteine and glutathione on inhibition of Na+, K+-ATPase activity by aspartame metabolites in human erythrocyte membrane.
    Schulpis KH, Papassotiriou I, Parthimos T, Tsakiris T, Tsakiris S.
    Eur J Clin Nutr; 2006 May; 60(5):593-7. PubMed ID: 16391576
    [Abstract] [Full Text] [Related]

  • 8. Neurophysiological symptoms and aspartame: What is the connection?
    Choudhary AK, Lee YY.
    Nutr Neurosci; 2018 Jun; 21(5):306-316. PubMed ID: 28198207
    [Abstract] [Full Text] [Related]

  • 9. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease.
    Hertelendy ZI, Mendenhall CL, Rouster SD, Marshall L, Weesner R.
    Am J Gastroenterol; 1993 May; 88(5):737-43. PubMed ID: 8480740
    [Abstract] [Full Text] [Related]

  • 10. Comparative metabolism of aspartame in experimental animals and humans.
    Ranney RE, Oppermann JA, Muldoon E, McMahon FG.
    J Toxicol Environ Health; 1976 Nov; 2(2):441-51. PubMed ID: 827618
    [Abstract] [Full Text] [Related]

  • 11. Comments on the purported generation of formaldehyde and adduct formation from the sweetener aspartame.
    Tephly TR.
    Life Sci; 1999 Nov; 65(13):PL157-60. PubMed ID: 10503962
    [Abstract] [Full Text] [Related]

  • 12. Neurobiochemical alterations induced by the artificial sweetener aspartame (NutraSweet).
    Coulombe RA, Sharma RP.
    Toxicol Appl Pharmacol; 1986 Mar 30; 83(1):79-85. PubMed ID: 2420032
    [Abstract] [Full Text] [Related]

  • 13. Saccharin and aspartame. Are they safe to consume during pregnancy?
    London RS.
    J Reprod Med; 1988 Jan 30; 33(1):17-21. PubMed ID: 3351801
    [Abstract] [Full Text] [Related]

  • 14. A new application of molecularly imprinted materials.
    Ye L, Ramström O, Månsson MO, Mosbach K.
    J Mol Recognit; 1998 Jan 30; 11(1-6):75-8. PubMed ID: 10076810
    [Abstract] [Full Text] [Related]

  • 15. Aspartame and its effects on health: approach seems simplistic in electronic responses to editorial.
    Finer N.
    BMJ; 2005 Feb 05; 330(7486):310; author reply 310. PubMed ID: 15695287
    [No Abstract] [Full Text] [Related]

  • 16. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
    Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, Waddell WJ, Walker R, Williams GM.
    Crit Rev Toxicol; 2007 Feb 05; 37(8):629-727. PubMed ID: 17828671
    [Abstract] [Full Text] [Related]

  • 17. Aspartame. Review of safety issues. Council on Scientific Affairs.
    JAMA; 1985 Jul 19; 254(3):400-2. PubMed ID: 2861297
    [Abstract] [Full Text] [Related]

  • 18. A review of the metabolism of the aspartyl moiety of aspartame in experimental animals and man.
    Ranney RE, Oppermann JA.
    J Environ Pathol Toxicol; 1979 Jul 19; 2(4):979-85. PubMed ID: 376770
    [Abstract] [Full Text] [Related]

  • 19. Can aspartame meet our expectations?
    Horwitz DL, Bauer-Nehrling JK.
    J Am Diet Assoc; 1983 Aug 19; 83(2):142-6. PubMed ID: 6348131
    [Abstract] [Full Text] [Related]

  • 20. L-Cysteine and glutathione restore the reduction of rat hippocampal Na+, K+-ATPase activity induced by aspartame metabolites.
    Simintzi I, Schulpis KH, Angelogianni P, Liapi C, Tsakiris S.
    Toxicology; 2007 Jul 31; 237(1-3):177-183. PubMed ID: 17602817
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.